9 cents stock .. who are the institutions? Maybe some people from institutions, right? Like from mental health care clinic?
What bogus K-1? Are you saying they did send out incorrect K-1? I didn't find anything about it. Or are you just unhappy with a tax law and the pass through entity rules? The second has nothing to do with Line, you have to talk to you congressman.
I think RAS is poorly managed. Many missteps, like Taberna debacle, over-issuing preferred shares, disaster with cutting the dividend in half show how bad the management is. I am long RFT and RFTA because I believe the equity cushion is sufficient for me to feel comfortable. I have measly 50 preferred shares, just for the fun.
I don't understand who is buying the common.
This is posted on RAS website. I am not a lawyer, anyway, this is what I read:
= in the past, to resolve SEC investigation RAS paid more money to SEC than they received on the fee from Taberna
= somebody did sue management for mishandling Taberna (fee were charged that couldn't been)
= resolution is they will strengthen internal control
= management (current and former) is free to go, it's hard to prove anything
= RAS shareholders will pay $250 legal fees for this nonsense.
Let me know if you read it different.
if bondholders get equity, they will wipe out the current equity holders. How that would bring the shares over $1.50 is a mystery. More like $0.0005.
The high short interest doesn't make sense. I do understand that somebody was (or is) shorting ARNA, MNKD, OREX or similar. The point is the shorts are expecting poor sales after an FDA approval.
But PGNX? Why? I would say oral Relistor should do well, or at least OK. Current subc Relistor is doing fine. Plus Azedra is an orphan drug in a small market - it is easy to make a sales estimate. Plus they have some promising technology for cancer imaging. Market cap is $300M. I wouldn't short this one. I am long.
Green Salad is safe, effective and well tolerated. And recommended by doctors. Salad undervalued by 500%++!!!!!!!!!!!!!!!!!!!!!!!!!
Anybody noticed that the 10K filing in section 'Item 8. Financial Statements and Supplementary Data" says this is for December 31, 2014 consolidated statements, even though it should be 12/31/2015. This is incorrect. I wonder I should tell RAS or SEC to correct it. Not sure how to communicate this.
I have to agree with Imfrommo. They HAVE to report a book value per share. It's a GAAP requirement and I can assure you the auditor will not sign off on the financials without it.